Graeme McRobbie
Associate Director Formulation Science Radiopharmaceuticals, Bicycle Therapeutics plc
Graeme McRobbie holds a PhD in Medicinal Chemistry from the University of Hull and has over 17 years of experience as a CMC radiopharmaceutical scientist working in nuclear medicine. He began his career at GE Healthcare and is currently an Associate Director of Formulation Science at Bicycle Therapeutics. He specializes in the design and development of radiopharmaceutical drug products and their manufacturing processes. His expertise spans the entire product lifecycle, from research and innovation through to early-stage clinical studies and commercial readiness.
Events Graeme McRobbie has spoken at
- Targeted Radiopharmaceuticals Summit EU 2026 8 December 2026 – 10 December 2026